Proton Pump Inhibitors in Pediatric Patients

Sandritter T. Gastroesophageal reflux disease in infants and children. J Pediatr Health Care 2003; 17 (4): 198–203

Rudolph CD Mazur LJ Liptak GS Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32 Suppl 2: S1–31

Jung AD. Gastroesophageal reflux in infants and children. Am Fam Physician 2001; 64 (11): 1853–60

Marchetti F Gerarduzzi T Ventura A. Proton pump inhibitors in children: a review. Dig Liver Dis 2003; 35 (10): 738–46

Gibbons TE Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs 2003; 5 (1): 25–40

Armstrong D Marshall JK Chiba N Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults — update 2004. Can J Gastroenterol 2005; 19 (1): 15–35

Repchinsky C , editor. Compendium of pharmaceuticals and specialties. Ottawa: Canadian Pharmacists Association; 2006

Lexi-Comp Inc. Lexi-Drugs. Hudson: Lexi-Comp Inc.; 2005

Zimmermann A Walters JK Katona B Alternative methods of proton pump inhibitor administration. Consult Pharm 1997; 12 (9): 990–8

Walters JK Zimmermann AE Souney PF The use of omeprazole in the pediatric population. Ann Pharmacother 1998; 32 (4): 478–81

The Hospital for Sick Children. Parent Med-Aid: omeprazole. Toronto: The Hospital for Sick Children; 1997

Personal communication. Lau E, Drug Information Coordinator. The Hospital for Sick Children. July 21, 2006

DiGiacinto JL Olsen KM Bergman KL Hole EB. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes. Ann Pharmacother 2000; 34 (5): 600–5